Regeneron intends to have COVID-19 treatments ready for clinical trials by the end of summer

Local

RENSSELAER, N.Y. (NEWS10) — Regeneron has released its timeline for a SARS-COV-2/COVID-19 treatment. A representative says the company plans to have doses ready for clinical trials by the end of August.

Regeneron started exploring ways to develop a treatment in January. They have since started working with U.S. Health and Human Services to develop novel coronavirus antibodies.

They are scheduled to start screening candidates for the most potent antibodies in March and will move to start manufacturing/animal testing the treatment in the spring/summer.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Download our news app

App Store Link
Google Play Link
REMARKABLE WOMEN_2022_NOMINATE

Latest PODCAST episode

More PODCAST: On the Story with Trishna Begam
CHECK OUT OUR NEW APP FEATURES

Latest COVID-19 News

More COVID-19